Curated News
By: NewsRamp Editorial Staff
October 19, 2026
Cotecna Acquires Energon Labs to Boost Pharma Testing in India
TLDR
- Cotecna's acquisition of Energon Labs gives it a strategic foothold in India's fast-growing pharma testing market and expands its global Life Sciences platform.
- Cotecna acquired Hyderabad-based Energon Labs, a USFDA-inspected, ISO-certified analytical testing lab, integrating its pharmaceutical testing capabilities into Cotecna's global network.
- The acquisition strengthens regulatory-compliant testing capacity, helping ensure safer pharmaceuticals and medical devices reach patients across India and worldwide.
- Energon Labs offers specialized services like extractables and leachables testing, glass delamination studies, and peptide characterization from Hyderabad's pharma hub.
Impact - Why it Matters
This acquisition matters because it significantly strengthens the global pharmaceutical testing infrastructure at a time when demand for rigorous quality and regulatory compliance is higher than ever. By integrating Energon Labs' USFDA-inspected, cGMP-compliant laboratory in Hyderabad—a key hub for pharmaceutical manufacturing—Cotecna expands its ability to serve both Indian and international customers across the product lifecycle. For patients and healthcare providers, this means more reliable testing and faster access to safe, effective medicines. For the industry, it signals continued investment in India's growing role as a critical link in global healthcare supply chains, ultimately enhancing the resilience and quality of the pharmaceutical market worldwide.
Summary
Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, has acquired Energon Labs, a cGMP-compliant, USFDA-inspected, ISO 9001:2015 and ISO 17025:2017 certified analytical testing laboratory based in Hyderabad, India. The acquisition, announced on October 19, 2026, strengthens Cotecna's global Life Sciences platform and expands its pharmaceutical testing capabilities across the Pharmaceutical, Biopharmaceutical, Medical Device and Packaging sectors. Energon serves customers across India, the United States, Asia-Pacific, and the Middle East and is recognized for its scientific excellence, regulatory expertise, and commitment to quality. The strategic location in Hyderabad, one of the world's leading pharmaceutical and biotechnology hubs, provides Cotecna with access to specialized scientific talent, advanced laboratory infrastructure, and a well-established pharmaceutical ecosystem. India is also one of the world's fastest-growing pharmaceutical markets and a critical manufacturing hub for global healthcare supply chains.
The acquisition enhances Cotecna's ability to support both Indian and international customers with high-quality, regulatory-compliant testing services while delivering greater responsiveness, scalability, and operational efficiency across key markets. Energon further complements Cotecna's growing pharmaceutical testing network, which includes Cotecna Life Sciences, Shiva Analyticals, and Neotron Pharma. Together, these capabilities strengthen the Group's ability to support customers throughout the product lifecycle and address evolving global quality, compliance, and regulatory requirements. Energon offers a comprehensive portfolio of analytical testing and quality assurance services, including analytical method development and validation, stability studies, impurity profiling, extractables and leachables, glass delamination studies, peptide and oligonucleotide characterisation, raw material and finished product testing, in-vitro binding studies, packaging compatibility studies, and regulatory support services.
Sebastien Dannaud, Chief Executive Officer of Cotecna Group, commented: “We are pleased to welcome Energon Labs to the Cotecna Group. This acquisition represents another important step to support our ambition to become one of the largest providers of Life Sciences testing services in India, and strengthens our position in one of the world's most important pharmaceutical markets.” Amit Chopra, CEO South Asia and Middle East, Cotecna Group, added: "I am delighted to welcome Manikanth Reddy and the talented team of Energon Labs to the Cotecna group. This acquisition aligns perfectly with our strategy of building a comprehensive pharmaceutical testing ecosystem across key growth markets." Manikanth Reddy, Founder of Energon, said: "Joining the Cotecna Group opens an exciting new chapter for Energon Labs. Over the years, we have focused on building a laboratory recognized for quality, scientific expertise and reliability. Becoming part of a global organization like Cotecna provides new opportunities to expand our capabilities, strengthen our service offerings and deliver even greater value to our customers." The original release can be viewed on www.newmediawire.com.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, Cotecna Acquires Energon Labs to Boost Pharma Testing in India
